Menetrier Disease

Menetrier Disease is a rare gastrointestinal disorder characterized by the overgrowth of mucous cells in the stomach lining. This condition leads to enlarged gastric folds, often resembling polyps, and can significantly impact digestive function.

Menetrier Disease

Key Takeaways

  • Menetrier Disease is a rare stomach disorder involving enlarged gastric folds.
  • It often causes protein loss, leading to edema and other symptoms.
  • Diagnosis typically involves endoscopy with biopsy to confirm characteristic changes.
  • Treatment focuses on symptom management, protein replacement, and sometimes medication or surgery.
  • Prognosis varies, with some cases resolving spontaneously and others requiring long-term management.

What is Menetrier Disease?

Menetrier Disease is a rare chronic condition affecting the stomach, characterized by massive enlargement of the gastric folds, particularly in the fundus and body of the stomach. This hypertrophy of the mucous-producing cells (foveolar hyperplasia) leads to excessive protein loss into the gastrointestinal tract, a condition known as protein-losing gastropathy. The exact prevalence is unknown due to its rarity, but it is more commonly diagnosed in adults, though pediatric cases have been reported. The disease can lead to significant health complications if left untreated, primarily due to the severe protein loss.

Menetrier Disease Symptoms and Diagnosis

The Menetrier disease symptoms and diagnosis involve recognizing a range of clinical manifestations and confirming them through specific diagnostic procedures. Common symptoms arise primarily from protein loss and inflammation of the stomach lining.

Symptoms may include:

  • Epigastric pain or discomfort
  • Nausea and vomiting
  • Loss of appetite and weight loss
  • Edema (swelling), particularly in the legs, due to low blood protein levels (hypoproteinemia)
  • Diarrhea
  • Gastrointestinal bleeding (less common but possible)

Diagnosis typically begins with a thorough medical history and physical examination. Laboratory tests often reveal low serum albumin levels, indicative of protein-losing gastropathy. The definitive diagnosis relies on endoscopic examination with biopsies. During endoscopy, characteristic enlarged, tortuous gastric folds are observed. Biopsies confirm the foveolar hyperplasia and glandular atrophy, which are hallmarks of the disease. Imaging studies such as barium swallow or CT scans may also show the thickened gastric folds, but endoscopy with biopsy remains crucial for confirmation.

Causes, Treatment, and Prognosis of Menetrier Disease

The precise causes and treatment for Menetrier disease are not fully understood, but several factors are implicated. In adults, some cases have been linked to an overproduction of transforming growth factor-alpha (TGF-α) in the stomach lining. In children, it is often associated with infections, particularly with Cytomegalovirus (CMV), and may resolve spontaneously once the infection clears.

Treatment strategies aim to manage symptoms, correct protein deficiencies, and address the underlying gastric changes. Medical management often includes a high-protein diet to counteract protein loss, diuretics to manage edema caused by hypoproteinemia, and proton pump inhibitors (PPIs) to reduce stomach acid and alleviate pain. Cetuximab, an epidermal growth factor receptor (EGFR) inhibitor, has shown promise in some adult cases by targeting the TGF-α pathway. Antiviral medications are used for pediatric cases linked to CMV infection.

In severe cases where medical therapy is ineffective or complications like significant bleeding or obstruction occur, surgical intervention, such as a partial or total gastrectomy (removal of part or all of the stomach), may be necessary.

The Menetrier disease prognosis and outlook vary significantly among individuals. In children, the condition often resolves spontaneously, especially when associated with viral infections. For adults, the disease is typically chronic and requires ongoing management. While some patients respond well to medical therapy, others may experience persistent symptoms or require surgical intervention. Long-term monitoring is essential due to a potential, albeit rare, increased risk of gastric adenocarcinoma, although this association is still debated and requires further research. Regular follow-up with a gastroenterologist is crucial to manage symptoms and monitor for any complications.

[EN] Cancer Types

Cancer Clinical Trial Options

Specialized matching specifically for oncology clinical trials and cancer care research.

Your Birthday


By filling out this form, you’re consenting only to release your medical records. You’re not agreeing to participate in clinical trials yet.